benzimidazole has been researched along with Prostatic Hyperplasia in 1 studies
1H-benzimidazole : The 1H-tautomer of benzimidazole.
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mori, F | 1 |
| Tanigawa, K | 1 |
| Endo, K | 1 |
| Minamiguchi, K | 1 |
| Abe, M | 1 |
| Yamada, S | 1 |
| Miyoshi, K | 1 |
1 other study available for benzimidazole and Prostatic Hyperplasia
| Article | Year |
|---|---|
VAT-1 is a novel pathogenic factor of progressive benign prostatic hyperplasia.
Topics: Adenosine Triphosphatases; Animals; Benzimidazoles; Cell Proliferation; Cells, Cultured; Disease Pro | 2011 |